Abstract

Abstract CT117: A Phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call